CD274 and cancer: The reduced copper content not only inhibits tumor neovascularization, but also inhibits the phosphorylation of EGFR and STAT3, promotes ubiquitin-mediated degradation of PD-L1 and inhibits PD-L1 transcription, eventually blocks cancer immune escape (Scheme 1B).